Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

2005 approvals: Safety first

Nature Reviews Drug Discovery volume 5, pages 92–93 (2006)Cite this article

Analysts say that Vioxx has had a significant effect on drug approvals

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Simon Frantz
    View author publications

    You can also search for this author in PubMed Google Scholar

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frantz, S. 2005 approvals: Safety first. Nat Rev Drug Discov 5, 92–93 (2006). https://doi.org/10.1038/nrd1973

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1973

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing